- Home
- COLL vs NSSC Comparison
COLL vs NSSC Comparison
Compare COLL & NSSC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- COLL
- NSSC
- Stock Information
- Founded
- COLL 2002
- NSSC 1969
- Country
- COLL United States
- NSSC United States
- Employees
- COLL N/A
- NSSC N/A
- Industry
- COLL Biotechnology: Pharmaceutical Preparations
- NSSC Telecommunications Equipment
- Sector
- COLL Health Care
- NSSC Telecommunications
- Exchange
- COLL Nasdaq
- NSSC Nasdaq
- Market Cap
- COLL 910.2M
- NSSC 899.1M
- IPO Year
- COLL 2015
- NSSC N/A
- Fundamental
- Price
- COLL $26.79
- NSSC $22.88
- Analyst Decision
- COLL Strong Buy
- NSSC Strong Buy
- Analyst Count
- COLL 5
- NSSC 5
- Target Price
- COLL $43.60
- NSSC $37.00
- AVG Volume (30 Days)
- COLL 393.2K
- NSSC 490.0K
- Earning Date
- COLL 05-08-2025
- NSSC 05-05-2025
- Dividend Yield
- COLL N/A
- NSSC 2.18%
- EPS Growth
- COLL 43.56
- NSSC 12.99
- EPS
- COLL 1.86
- NSSC 1.31
- Revenue
- COLL $631,449,000.00
- NSSC $186,533,000.00
- Revenue This Year
- COLL $19.96
- NSSC N/A
- Revenue Next Year
- COLL $3.93
- NSSC $7.11
- P/E Ratio
- COLL $14.31
- NSSC $17.50
- Revenue Growth
- COLL 11.41
- NSSC 5.14
- 52 Week Low
- COLL $23.23
- NSSC $19.00
- 52 Week High
- COLL $42.29
- NSSC $58.09
- Technical
- Relative Strength Index (RSI)
- COLL 43.80
- NSSC 52.26
- Support Level
- COLL $25.87
- NSSC $21.14
- Resistance Level
- COLL $27.95
- NSSC $22.35
- Average True Range (ATR)
- COLL 1.50
- NSSC 1.07
- MACD
- COLL 0.05
- NSSC 0.32
- Stochastic Oscillator
- COLL 69.33
- NSSC 98.73
About COLL Collegium Pharmaceutical Inc.
Collegium Pharmaceutical Inc is a specialty pharmaceutical company. The company is engaged in developing and planning to commercialize abuse-deterrent products that incorporate its patented DETERx platform technology for the treatment of chronic pain and other diseases. The DETERx platform technology is designed to maintain the extended-release and safety profiles of abused drugs in the face of various methods including chewing, crushing, and dissolving. Its product portfolio includes Jornay, Xtampza ER, which is an abuse-deterrent, extended-release, oral formulation of oxycodone; and Nucynta Products, which are extended-release and immediate-release formulations of tapentadol; Belbuca, and Symproic.
About NSSC NAPCO Security Technologies Inc.
NAPCO Security Technologies Inc manufactures security products, encompassing access control systems, door-locking products, intrusion and fire alarm systems and video surveillance products. Its products are used for various applications which includes alarm systems like automatic communicators, combination control panels/digital communicators and digital keypad systems, fire alarm control panel and area detectors mainly used for commercial, residential, institutional, industrial and governmental uses. Geographically, the company derives a majority of its revenue from the United States.